Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renacon Pharma is a Pakistan-based healthcare manufacturer focused on products used in hemodialysis treatment rather than a drug-discovery biotech pipeline. The company is best known for bicarbonate and citrate hemodialysis concentrates in solution, powder, cartridge, and bag formats, and also offers dialysis disinfectants, automated mixers, reverse-osmosis water treatment plants, dialyzers, blood lines, AV fistula needles, and related renal-care consumables. Founded in 1996 by Dr. Salman Shakoh, the business later became part of the Treet Group and markets itself as a pioneer in hemodialysis concentrates in Pakistan and Asia. Its business model is centered on manufacturing, export, custom formulation, and cost-effective dialysis infrastructure for clinics and distributors, with commercial activity across multiple international markets. This is a commercial-stage renal-care products company, not a therapeutics developer with named molecular targets or traditional clinical trial programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Renacon Pharma.